Article Details

HBM portfolio company Ambrx Biopharma raises USD 126 million in initial public offering on New ...

Retrieved on: 2021-06-21 04:41:15

Tags for this article:

Click the tags to see associated articles and topics

HBM portfolio company Ambrx Biopharma raises USD 126 million in initial public offering on New .... View article details on hiswai:

Excerpt

After the IPO, HBM Healthcare Investments holds 2.54 million ADS with a total value of USD 43.25 million. Ambrx Biopharma is developing a novel class ...

Article found on: uk.sports.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up